Loading insider details...
Beta
Latest Form 4 (May 11, 2026): Grant/Award of 1,015 RVTY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 11, 2026 | REVVITY, INC. (RVTY) | Grant/Award | 1,015 | n/a |
| Mar 4, 2026 | Eikon Therapeutics, Inc. (EIKN) | Grant/Award | 87,157 | n/a |
| May 1, 2025 | REVVITY, INC. (RVTY) | Grant/Award | 1,074 | n/a |
| May 6, 2024 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 887 | $113.1K |
| May 2, 2024 | Merck & Co., Inc. (MRK) | Grant/Award | 20,508 | n/a |
| May 2, 2024 | REVVITY, INC. (RVTY) | Grant/Award | 977 | n/a |
| Feb 16, 2024 | REVVITY, INC. (RVTY) | Grant/Award | 217 | n/a |
| Jan 24, 2024 | Merck & Co., Inc. (MRK) | Grant/Award | 3,896 | $465.3K |
| May 5, 2023 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 885 | $104.6K |
| May 4, 2023 | Merck & Co., Inc. (MRK) | Grant/Award | 20,747 | n/a |